1. Introduction {#s0005}
===============

Medications have caused and will continue to cause harm to a number of people's lives alongside many benefits. Adverse Drug Reactions (ADRs) are a major problem and are one of the leading causes of mortality and morbidity ([@b0070; @b0035]). Adverse drug reaction (ADR) is defined according to [@b0095] as any response to a drug which is noxious and unintended and occurs at doses normally used in man for prophylaxis, diagnosis or therapy of disease or the modification of physiological function.

ADRs are associated with prolonged length of hospital stay, increased economic burden and increased death. Many studies have reported that ADRs were responsible for large numbers of hospital admissions ([@b0070; @b0065; @b0085; @b0005]). In the United States, more than 100,000 deaths are attributed annually to serious adverse drug reactions ([@b0070]). In the UK, about 6.5% of all admissions to hospitals are due to an ADR, and the overall fatality was 0.15% ([@b0085]). A prospective study by [@b0005] demonstrated that drug-related problems report in Saudi Arabia showed that the mortality rate associated with ADRs in provincial hospitals was found to be 3.8% from the overall deaths in the general practice. There are differences among countries and regions within countries in the occurrence of drug-related problems. This may be due to differences in diseases, prescribing practices, genetics, diet habits and use of herbal remedies which may pose specific toxic problems. Under-reporting of adverse drug reactions (ADRs) is very common. It has been estimated that only 6--10% of all the ADRs are reported ([@b0050]).

There is a considerable increase in awareness about the issues related to drug safety among healthcare providers, healthcare institutions and the public. The term pharmacovigilance has evolved to recognize the importance for monitoring and improving the safe use of medicines.

World Health Organization ([@b0100]) defines pharmacovigilance as "the science and activities relating to the detection, evaluation, understanding, and prevention of adverse reactions to medicines or any other medicine-related problems". [@b0105], located in Uppsala, Sweden, is the field name for the World Health Organization Collaborating Centre for International Drug Monitoring. The UMC works by collecting, assessing and communicating information from member countries' national programs in regard to the benefits, harm, effectiveness and risks of drugs.

A national pharmacovigilance center was established by [@b0090] in March 2009 and it is one member of the WHO Collaborating Centre in Uppsala, Sweden. The national pharmacovigilance system is the main way to collect information about ADRs occurrences in both the hospital and community settings. The effectiveness and success of any pharmacovigilance system depend highly on the participation of all healthcare professionals and the degree of co-operation and communication between the practitioners and pharmacovigilance center.

There is a lack of studies that address the knowledge, attitudes and perception of healthcare professionals toward the pharmacovigilance system and ADRs reporting, which is carried out in this country. In a country like Saudi Arabia with multiethnic groups and a high rate of use of herbal and complementary medicine, practitioners can play a major role in detecting and reporting ADRs associated with the use of such products. It is important to conduct comprehensive studies to explore and evaluate the roles of healthcare professionals and their contributions in the pharmacovigilance activities. The aim of the present study was to assess the knowledge and awareness of ADRs reporting and pharmacovigilance system among the healthcare professionals in Al-Madinah Al-Munawwarah Hospitals, Kingdom of Saudi Arabia.

2. Materials and methods {#s0010}
========================

2.1. Design of the questionnaire {#s0015}
--------------------------------

A questionnaire was developed to obtain information on the knowledge and awareness of pharmacovigilance and adverse drug reactions reporting, availability of ADRs reporting systems, patient counseling about ADRs and documentation of ADRs.

2.2. Hospitals visits {#s0020}
---------------------

The healthcare professionals (physicians, pharmacists, nurses and pharmacist' technicians) of some 9 hospitals were provided with a copy of the questionnaire after explanation of the objectives of the study. The healthcare professionals were provided with enough time to fill the questionnaire. The questionnaire was explained to each practitioner in order to preclude any potential misunderstanding, and also the name of the participant was made optional.

2.3. Healthcare professionals participation {#s0025}
-------------------------------------------

A total 585 questionnaires were circulated, and a total of 384 healthcare professionals responded to fill the questionnaire ([Table 1](#t0005){ref-type="table"}). Healthcare professional categories involved were 148 physicians, 37 pharmacists, 41 pharmacist technicians and 158 nurses. A total of 201 of the healthcare professionals refused to participate in the study. [Table 2](#t0010){ref-type="table"} shows the respondents' nationalities from different hospitals visited. The questionnaire consisted of information about familiarity with the ADRs reporting and pharmacovigilance system, attitude toward ADRs reporting and patient counseling about ADRs and documentation of ADRs.

2.4. Collection of questionnaires and analysis of data {#s0030}
------------------------------------------------------

Complete questionnaires were collected from each participant in each hospital to evaluate the awareness of pharmacovigilance knowledge and ADRs reporting among healthcare professionals. Data were analyzed and presented as a percent (%) of the respondents. In case of unanswered questions, a participant was excluded from the study.

3. Results {#s0035}
==========

A total 384 healthcare professionals participated in the study and the overall percent of the respondents who accepted to enroll in the study was 65.64%. The major reasons for non-participation were being too busy and/or unwilling to participate, too busy or fear. Healthcare professionals to participate in the study were 148 physicians, 37 pharmacists, 41 pharmacist technicians and 158 nurses. A total of 201 of the healthcare professionals refused to participate in the study.

3.1. Awareness of the healthcare professionals of pharmacovigilance system {#s0040}
--------------------------------------------------------------------------

The healthcare professionals (physicians, pharmacists, nurses and pharmacist technicians) were asked about their knowledge of the pharmacovigilance in KSA. Most of the practitioners were unfamiliar with the availability of national pharmacovigilance system in KSA. The total percent of the respondent's knowledge of national pharmacovigilance system in KSA was 39.6% ([Fig. 1](#f0005){ref-type="fig"}). The highest percent of the awareness of pharmacovigilance system was among the pharmacists (70.27%), pharmacists' technicians (61%), physicians (39.2%), and nurses were 27.2% ([Fig. 2](#f0010){ref-type="fig"}). The awareness of the healthcare professionals of pharmacovigilance by nationality distribution is presented in [Fig. 3](#f0015){ref-type="fig"}. This figure shows that the number of Saudi nationality was the highest, followed by Sudanese, Egyptian, Syrian and Philippines. One of the limits of this interpretation was the small number of the Saudi and Sudanese participated in the study.

3.2. Availability of a pharmacovigilance system in hospitals {#s0045}
------------------------------------------------------------

The healthcare professionals were then asked about the availability of pharmacovigilance system in their hospitals, the doctors had a high score followed by nurses, and then pharmacists. The response of the participants about the availability of pharmacovigilance system at their hospitals is shown in [Fig. 4](#f0020){ref-type="fig"}. It was observed that there was no electronic reporting system in all hospitals visited, which affects the availability and sharing of pharmacovigilance information among the different hospital departments ([Fig. 5](#f0025){ref-type="fig"}).

3.3. Awareness of adverse drug reactions (ADRs) reporting {#s0050}
---------------------------------------------------------

All respondents of healthcare professionals had a positive awareness for adverse drug reactions (ADRs) reporting. [Fig. 6](#f0030){ref-type="fig"} shows that a higher number of the healthcare professionals were aware of ADRs reporting, but practically it is not applied in the visited hospitals.

3.4. Frequency of encountering ADRs {#s0055}
-----------------------------------

The healthcare professionals were asked about the frequency of encountering ADRs during their daily work in hospitals. [Fig. 7](#f0035){ref-type="fig"} shows that physicians encountered ADRs occasionally, while pharmacists' technicians and nurses rarely encountered ADRs. Some pharmacists answered that they encountered ADRs occasionally, while others they encountered rarely depending on the hospital and the environment of practice.

3.5. Patient counseling about ADRs by healthcare professionals {#s0060}
--------------------------------------------------------------

Effective communication between healthcare professionals and patients is one of the most important elements for reducing ADRS and improving health outcomes. Therefore, healthcare professionals were asked about their role in counseling patients about ADRs. [Fig. 8](#f0040){ref-type="fig"} demonstrates that doctors had the highest percent (82.4%) among the other healthcare professional groups in counseling patients about ADRs. Around 75.7% of pharmacists and 73.4% of nurses were willing to counsel patients about ADRS.

3.6. Follow-up and documentation of ADRs in hospitals {#s0065}
-----------------------------------------------------

Follow-up and documentation is the cornerstone of the pharmacovigilance system in any hospital. A percent of 47.7% of physicians and 50.6% of nurses were aware of follow-up and documentation of ADRs in the visited hospitals ([Fig. 9](#f0045){ref-type="fig"}).

4. Discussion {#s0070}
=============

Adverse drug reactions (ADRs) are one of the most serious health problems, and are one of the leading causes of mortality and morbidity ([@b0085; @b0045]). There are differences among countries in the occurrence of drug-related problems; this may be due to differences in diseases, prescribing practices, diet, traditions of the people and the use of herbal remedies which may pose specific toxicological problems. Pharmacovigilance has grown in importance in recent years, and good pharmacovigilance systems will identify the risks of drug-related problems so that harm can be avoided. Pharmacovigilance deals with detection, assessment, understanding and prevention of adverse effects or any other drug related problems.

In a country like Saudi Arabia with multiethnic groups and a high rate of use of herbal and complementary medicine, practitioners can play a major role in detecting and reporting ADRs associated with the use of such products. It is important to conduct comprehensive studies to explore and evaluate the roles of healthcare professionals and contributions in the pharmacovigilance system activities. Despite the Saudi national pharmacovigilance center that regularly publishes an ADR bulletin, and information pertaining to ADRs is stored in a national ADRs database, there is a lack of studies that address the knowledge and awareness of healthcare professionals about the pharmacovigilance system and ADRs reporting in this country. The present study aimed to evaluate the knowledge, awareness of the healthcare professionals regarding pharmacovigilance and ADRs reporting. It was observed that the awareness of the availability of national pharmacovigilance system among healthcare professionals was 39.6%. Interestingly, pharmacists were the most knowledgeable group (70.27%) about pharmacovigilance and ADRs reporting, despite the absence of distinct pharmacovigilance systems or reporting systems in most hospitals. The findings in our study were reasonably similar to the observations made in both developing and developed countries. In China 71% of the healthcare professionals did not have knowledge of the reporting procedure ([@b0015]). In Malaysia, about 40% of the respondents were not aware of the existence of the national reporting system ([@b0080]). In the European Union (EU), many healthcare professionals did not know how to report an ADR ([@b0025]).

The healthcare professionals were asked about the availability of pharmacovigilance system at their hospitals, the majority of participants answered that there was no pharmacovigilance system in hospitals. It was noted that healthcare professionals (physicians, pharmacists, nurses and pharmacist technicians) working in hospitals have insufficient knowledge of pharmacovigilance practices. The main reasons for under-reporting of ADRs are lack of time, poor knowledge on the reporting mechanisms, unfamiliarity with the existence of national pharmacovigilance system, belief that the ADR was already well known, doubt about the importance of the ADRs reporting and fear to report ADRs ([@b0075; @b0060]). [@b0010] reported that only 18% of community pharmacists were aware of the ADR system and 56% of the respondents were not aware of the existence of the Saudi National Pharmacovigilance center. [@b0020] also reported that the majority of community pharmacists surveyed (86.8%) were not aware of the ADRs reporting program in Saudi Arabia and only twenty-nine percent of pharmacists were aware that pharmacists in Saudi Arabia could report an ADR to the Ministry of Health (MOH). A survey study in France showed that the majority of medical residents had minimal knowledge regarding pharmacovigilance ([@b0055]). Another study from Italy reported that doctors had little information regarding ADRs and ADR reporting systems ([@b0040]). In the UK, where pharmacovigilance programs are well established, there is a high level of under-reporting is documented ([@b0030]). Healthcare professionals should consider adverse drug reactions (ADRs) reporting as an obligation and should be aware of the existing pharmacovigilance mechanisms. The re-enforcement of pharmacovigilance systems in hospitals should be a priority basis for the success of the pharmacovigilance programs and the better clinical management of the patients.

5. Conclusions {#s0075}
==============

The present study pointed out to the lack of the knowledge and awareness among healthcare professionals of pharmacovigilance system and ADRs reporting systems in hospitals. The doctors, pharmacists and nurses have a great responsibility in reporting ADRs and strengthening the pharmacovigilance mechanisms. Our findings also provide the healthcare policy makers and health authorities with base line data that can be used in the future evaluation or re-enforcement plans and educational initiatives for improving the pharmacovigilance practices and ADRs reporting in hospitals.
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###### 

Total number of healthcare professional respondents in hospitals.

  Healthcare professional Respondents   Total (585)   Response   
  ------------------------------------- ------------- ---------- ----
  Pharmacists                           52            37         15
  Pharmacists' Technicians              68            41         27
  Physicians                            209           148        61
  Nurses                                253           158        95

###### 

Total number of healthcare professional respondents' nationalities in hospitals.

  Nationality   Total (585)   Accepted (384)   Rejected (201)
  ------------- ------------- ---------------- ----------------
  Egypt         159           105              54
  Saudi         181           107              74
  Sudan         39            32               7
  Syrian        27            17               10
  Philippine    173           117              56
  Jordon        5             5                0
  Pakistan      1             1                0
